🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Real-World Medication Utilization and Potential Pharmacokinetic Drug–Drug Interaction Liabilities in Patients with Heart Failure and Chronic Kidney Disease

Article C Peer reviewed Observational

Key takeaways

This study looked at medical records from 2019 to 2024. It found that people with heart failure and kidney disease often take many drugs. These drugs can interact in the body. This shows a risk, not proof of harm.

Who did this work

Mareena Biju (Boehringer Ingelheim (Japan)) · Annie Carlisle (Boehringer Ingelheim (Japan)) · Ling Zhang (Boehringer Ingelheim (Japan)) · Jennifer Schaible (Boehringer Ingelheim (Germany)) · Beshoy Armanios (University of Connecticut) · Xin Chen (University of Maryland, Baltimore) · Ashish Sharma (Boehringer Ingelheim (Japan)) · Fenglei Huang (Boehringer Ingelheim (Japan))

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-11
https://doi.org/10.3390/pharmaceutics18111462